DCs from patients with MM have reduced expression, or even absence, of costimulatory molecules [55] and this, along with high levels of IL-6, IL-10, and TGF-β within the bone marrow microenvironment, contributes to impaired T-cell costimulation and activation [55, 56]. The gene discussed is IL6; the disease is Miyoshi myopathy.